Compare Ginkgo Bioworks Holdings Inc (DNA) vs Alphabet Inc Class A (GOOGL) Price & Performance

DNA trades at $9.05, down 0.44% on the day, reflecting ongoing investor caution. The technical outlook is bearish, while fundamentals show significant losses with a net income margin of -201.05% and negative cash flows. Recent earnings have been mixed, missing estimates in two of the last three quarters. Analyst sentiment is divided, with a slight lean toward buy ratings amid high volatility and operational challenges.

The outlook remains challenging due to persistent losses and cash burn, though analyst coverage suggests potential long-term value. Key risks include execution missteps and intense competition in biotechnology. Investment appeal hinges on future profitability improvements and successful business model execution.

Alphabet (GOOGL) trades at $367.14, up 4.15% today, with a neutral technical signal and strong fundamentals. The stock shows robust profitability with a 37.92% net margin and consistent earnings beats, including Q1 2026 EPS of $5.11 versus $2.64 expected. Revenue grew to $402.84B in 2025, and operating cash flow surged to $164.71B. Analysts are overwhelmingly bullish with an 85.19% buy rating and a $431.78 consensus price target. Recent news highlights AI-driven growth opportunities, including partnerships and YouTube subscription price increases.

The outlook for GOOGL remains positive, supported by AI expansion and solid financials, but risks include antitrust scrutiny and market volatility. The stock offers upside to analyst targets, though investors should monitor competitive pressures and regulatory developments that could impact growth.